Aim of the Conference

We believe the attendees will target the following aims in the Congress:

1. Consolidate the concept of mechanism based targeted therapy of Parkinson's disease and related disorders
2. Understand the therapeutic challenge issues during the management of Parkinson's disease and movement disorders
3. Refresh the most update knowledge of common movement disorders including chorea, myoclonus, tremors, dystonia and newly immune-mediated movement disorders.
4. Secure the prestigious information of neurophysiology in cerebellum and basal ganglia circuitry and adopt the concept to clinical practice
5. Know how and when to use device aided therapy for the treatment of patients with movement disorders.
6. Learn the practically useful biomarkers and neuroimaging knowledge and know how to apply them for clinical studies and services.
7. Know the non-invasive neuromodulation tools, including rTMS and MRI guided focus ultrasound, and how to apply them for the investigation as well as management of patients with movement disorders.